Biomarker testing is a laboratory test in oncology that is used in the selection of targeted cancer treatments and helping to avoid ineffective treatments. There exist several types of biomarker tests that can be used to detect the presence of particular mutations or variation in gene expression. Whole Genome Sequencing (WGS) is a biomarker test for analyzing the entire genome. WGS can provide more comprehensive diagnostic information, but it is also more expensive than other tests. In this study, System Dynamics and Game Theoretic models are employed to evaluate scenarios, and facilitate organizational decision making regarding WGS implementation. These models evaluate the clinical and economic value of WGS as well as its affordability and accessibility. The evaluated scenarios have covered the timing of implementing WGS using time to diagnosis and total cost.
翻译:生物标志测试是一种肿瘤学实验室测试,用于选择有针对性的癌症治疗,帮助避免无效治疗; 存在几种生物标志测试,可用于检测是否存在特定突变或基因表达形式的变化; 整个基因组定序(WGS)是分析整个基因组的生物标志测试; WGS可以提供更全面的诊断信息,但也比其他测试更昂贵; 在这项研究中,系统动态和游戏理论模型用于评估情景,便利组织就实施WGS做出决策; 这些模型评估了WGS的临床和经济价值及其可承受性和可获取性; 评估的情景涵盖了利用时间进行诊断和总成本实施WGS的时间。